Pharmacology of Levosimendan: A New Myofilament Calcium Sensitizer

Abstract

Cardiovascular Drug ReviewsVolume 14, Issue 3 p. 286-316 Free to Read Pharmacology of Levosimendan: A New Myofilament Calcium Sensitizer Paul S. Pagel, Paul S. Pagel the Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorHeimo Haikala, Heimo Haikala Orion Corporation, the Orion Research Center, Espoo, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorPertti J. Pentikäinen, Pertti J. Pentikäinen the First Department of Medicine, Helsinki University Hospital, Helsinki, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorMarja-Leena Toivonen, Marja-Leena Toivonen Orion Corporation, the Orion Research Center, Espoo, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorMarkku S. Nieminen, Markku S. Nieminen the First Department of Medicine, Helsinki University Hospital, Helsinki, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorLasse Lehtonen, Lasse Lehtonen Orion Corporation, the Orion Research Center, Espoo, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorJulian Gy. Papp, Julian Gy. Papp the Department of Pharmacology, Albert Szent-Györgyi Medical University. Szeged, Hungary. Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorDavid C. Warltier, Corresponding Author David C. Warltier the Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinAddress correspondence and reprint requests to Dr. D. C. Warltier, Medical College of Wisconsin, MEB—Room 462C, 8701 Watertown Plank Road, Milwaukee. WI 53226. Fax: (414) 266-8541.Search for more papers by this author Paul S. Pagel, Paul S. Pagel the Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorHeimo Haikala, Heimo Haikala Orion Corporation, the Orion Research Center, Espoo, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorPertti J. Pentikäinen, Pertti J. Pentikäinen the First Department of Medicine, Helsinki University Hospital, Helsinki, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorMarja-Leena Toivonen, Marja-Leena Toivonen Orion Corporation, the Orion Research Center, Espoo, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorMarkku S. Nieminen, Markku S. Nieminen the First Department of Medicine, Helsinki University Hospital, Helsinki, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorLasse Lehtonen, Lasse Lehtonen Orion Corporation, the Orion Research Center, Espoo, Finland Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorJulian Gy. Papp, Julian Gy. Papp the Department of Pharmacology, Albert Szent-Györgyi Medical University. Szeged, Hungary. Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorDavid C. Warltier, Corresponding Author David C. Warltier the Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin Departments of Anesthesiology, Pharmacology, and Medicine (Division of Cardiovascular Diseases), Medical College of Wisconsin, Milwaukee, WisconsinAddress correspondence and reprint requests to Dr. D. C. Warltier, Medical College of Wisconsin, MEB—Room 462C, 8701 Watertown Plank Road, Milwaukee. WI 53226. Fax: (414) 266-8541.Search for more papers by this author First published: September 1996 https://doi.org/10.1111/j.1527-3466.1996.tb00232.xCitations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume14, Issue3September 1996Pages 286-316 RelatedInformation